Galectin-1:: a key effector of regulation mediated by CD4+CD25+ T cells

被引:394
作者
Garin, Marina I.
Chu, Chung-Ching
Golshayan, Dela
Cernuda-Morollon, Eva
Wait, Robin
Lechler, Robert I.
机构
[1] Kings Coll London, Guys Hosp, Sch Med, Dept Nephrol & Transplantat,Immunoregulat Lab, London SE1 1UL, England
[2] Kings Coll London, Kings Coll Hosp, Sch Med, Dept Nephrol & Transplantat,Immunoregulat Lab, London SE1 1UL, England
[3] Kings Coll London, St Thomas Hosp, Sch Med, Dept Nephrol & Transplantat,Immunoregulat Lab, London SE1 1UL, England
[4] CHU Vaudois, Div Nephrol, CH-1011 Lausanne, Switzerland
[5] CHU Vaudois, Transplant Ctr, CH-1011 Lausanne, Switzerland
[6] UCL Royal Free & Univ Coll Sch Med, Ludwig Inst Canc Res, London, England
[7] Univ London Imperial Coll Sci Technol & Med, Fac Med, Kennedy Inst Rheumatol, London SW7 2AZ, England
[8] CIEMAT, Lab Hematopoyesis & Terapia Gen, E-28040 Madrid, Spain
基金
英国医学研究理事会;
关键词
D O I
10.1182/blood-2006-04-016451
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The naturally occurring population of dedicated regulatory T cells that co-express CD4 and CD25 is known to play a key role in the maintenance of peripheral T-cell tolerance; however, their mechanism of action has remained obscure. Here we report that a member of the family of beta-galactoside-binding proteins, galectin-1, is overexpressed in regulatory T cells, and that expression is increased after activation. Most importantly, blockade of galectin-1 binding significantly reduced the inhibitory effects of human and mouse CD4(+)CD25(+) T cells. Reduced regulatory activity was observed in CD4(+)CD25(+) T cells obtained from galectin-1-homozygous null mutant mice. These results suggest that galectin-1 is a key effector of the regulation mediated by these cells.
引用
收藏
页码:2058 / 2065
页数:8
相关论文
共 40 条
[1]   CD4+CD25high regulatory cells in human peripheral blood [J].
Baecher-Allan, C ;
Brown, JA ;
Freeman, GJ ;
Hafler, DA .
JOURNAL OF IMMUNOLOGY, 2001, 167 (03) :1245-1253
[2]   Amelioration of graft versus host disease by galectin-1 [J].
Baum, LG ;
Blackall, DP ;
Arias-Magallano, S ;
Nanigian, D ;
Uh, SY ;
Browne, JM ;
Hoffmann, D ;
Emmanouilides, CE ;
Territo, MC ;
Baldwin, GC .
CLINICAL IMMUNOLOGY, 2003, 109 (03) :295-307
[3]   HUMAN THYMIC EPITHELIAL-CELLS EXPRESS AN ENDOGENOUS LECTIN, GALECTIN-1, WHICH BINDS TO CORE-2 O-GLYCANS ON THYMOCYTES AND T-LYMPHOBLASTOID-CELLS [J].
BAUM, LG ;
PANG, M ;
PERILLO, NL ;
WU, T ;
DELEGEANE, A ;
UITTENBOGAART, CH ;
FUKUDA, M ;
SEILHAMER, JJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (03) :877-887
[4]   CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity [J].
Belkaid, Y ;
Piccirillo, CA ;
Mendez, S ;
Shevach, EM ;
Sacks, DL .
NATURE, 2002, 420 (6915) :502-507
[5]  
Blaser C, 1998, EUR J IMMUNOL, V28, P2311, DOI 10.1002/(SICI)1521-4141(199808)28:08<2311::AID-IMMU2311>3.0.CO
[6]  
2-G
[7]   Galectin-1 induces partial TCR ζ-chain phosphorylation and antagonizes processive TCR signal transduction [J].
Chung, CD ;
Patel, VP ;
Moran, M ;
Lewis, LA ;
Miceli, MC .
JOURNAL OF IMMUNOLOGY, 2000, 165 (07) :3722-3729
[8]  
FRED BC, 2002, BIOCHIM BIOPHYS ACTA, V1572, P255
[9]   Presentation of galectin-1 by extracellular matrix triggers T cell death [J].
He, JL ;
Baum, LG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (06) :4705-4712
[10]   Ah, sweet mystery of death! Galectins and control of cell fate [J].
Hernandez, JD ;
Baum, LG .
GLYCOBIOLOGY, 2002, 12 (10) :127R-136R